Merrimack Receives Fast Track For Pancreatic Cancer Drug

The reason the FDA gave MACK Fast Track approval is because there are no current therapies for pancreatic cancer -- the drug meets an unmet medical need.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.